Antonina Mitrofanova
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Oncology top 10%
- Cell Biology top 10%
- Co-authors
- Andrea CalifanoCory Abate‐ShenMichael M. ShenRobert D. CardiffÀlvaro AytésSarah K. BergrenCéline LefèbvreZhu A. Wang
- Topics
- Prostate Cancer Treatment and Research (19 papers)Prostate Cancer Diagnosis and Treatment (6 papers)Bioinformatics and Genomic Networks (6 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Antonina Mitrofanova
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 882
- Pulmonary and Respiratory Medicine 721
- Cancer Research 420
- Oncology 362
- Cell Biology 116
Countries citing papers authored by Antonina Mitrofanova
This map shows the geographic impact of Antonina Mitrofanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonina Mitrofanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonina Mitrofanova more than expected).
Fields of papers citing papers by Antonina Mitrofanova
This network shows the impact of papers produced by Antonina Mitrofanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonina Mitrofanova. The network helps show where Antonina Mitrofanova may publish in the future.
Co-authorship network of co-authors of Antonina Mitrofanova
This figure shows the co-authorship network connecting the top 25 collaborators of Antonina Mitrofanova. A scholar is included among the top collaborators of Antonina Mitrofanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonina Mitrofanova. Antonina Mitrofanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 15 | |
| 5 | 14 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 8 | |
| 9 | 15 | |
| 10 | 33 | |
| 11 | 240 | |
| 12 | 13 | |
| 13 | 25 | |
| 14 | 28 | |
| 15 | 233 | |
| 16 | 243 | |
| 17 | 68 | |
| 18 | 78 | |
| 19 | 3 | |
| 20 | 8 |
About Antonina Mitrofanova
Antonina Mitrofanova is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Bioinformatics and Genomic Networks (6 papers). The work is most often cited by research in Cancer Research (420 citations), Pulmonary and Respiratory Medicine (721 citations) and Oncology (362 citations). Antonina Mitrofanova has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Andrea Califano, Cory Abate‐Shen, Michael M. Shen, Robert D. Cardiff, Àlvaro Aytés, Sarah K. Bergren, Céline Lefèbvre, Zhu A. Wang, Clémentine Le Magnen and Nicolas Floc’h. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.